BiologicalDrug
Candida albicans Antigen Injection clinical trials
Keep track of what changes. Save the Candida albicans Antigen Injection studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 3
Janssen Research & Development, LLC (4) · Nielsen BioSciences, Inc. (2) · University of Michigan (1) · University of Arkansas (1) · Tonix Pharmaceuticals, Inc. (1) · Universidad Autonoma de Nuevo Leon (1)
Often tested with
Tested in the same studies.
Histamine phosphate (1) · Histamine (1) · Imiquimod (1) · Secukinumab (1) · MVA-BN smallpox vaccine (1) · Shingrix (1) · Escherichia coli lipopolysaccharide (1) · Belimumab (1)
Studies
Open first, then newest update. How each study uses Candida albicans Antigen Injection is read from its arms, and is right about nine times in ten.
Testing it · 10
- Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce RecurrenceRecruitingPhase 2University of ArkansasNCT05952934Written as 0.5 mL Candin®/injection
- Immunologic Profile of Chronically Photodamaged SkinCompletedPhase 1University of MichiganNCT02889159Written as Candida albicans antigen
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1CompletedPhase 1Janssen Research & Development, LLCNCT04589026Written as Candin
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4CompletedPhase 1Janssen Research & Development, LLCNCT05522517Written as Candin
- A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy ParticipantsCompletedEarly Phase 1Janssen Research & Development, LLCNCT03953196Written as Candin
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2CompletedPhase 1Janssen Research & Development, LLCNCT04611971Written as Candin
- Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide AntigensTerminatedPhase 1Tonix Pharmaceuticals, Inc.NCT05216510Written as CANDIN
- Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia AreataStatus unknownNot applicableUniversidad Autonoma de Nuevo LeonNCT06564805Written as Candida Albicans Antigen Injection
- Candin Safety & Efficacy Study for the Treatment of WartsCompletedPhase 2Nielsen BioSciences, Inc.NCT01757392Written as Candida albicans Skin Test Antigen
- Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)CompletedPhase 2Nielsen BioSciences, Inc.NCT02393417Written as CANDIN
As the comparator · 2 — what is tested is compared with Candida albicans Antigen Injection
- A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial LesionsCompletedPhase 2University of ArkansasNCT02481414Written as Candin®
- Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost VaccinationCompletedPhase 2Mark HatherillNCT01650389Written as Candin